...
首页> 外文期刊>Journal of Virological Methods >Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.
【24h】

Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector.

机译:从用烟草花叶病毒(TMV)衍生的载体接种的植物中高产量产生和纯化的HIV-1 p24的保留抗原性。

获取原文
获取原文并翻译 | 示例
           

摘要

Production of structural proteins from foot-and-mouth disease virus (FMDV) and bovine herpes virus (BHV-1) in Nicotiana benthamiana through the use of a tobacco mosaic virus-based vector (TMV-30B) has been reported previously. The development of the TMV-30B-HISc vector, a new version that adds a C-terminal histidine (His) sequence to the foreign protein expressed is described. Coding sequences from the FMDV VPl protein and the core protein, p24, from a clade C HIV-1 isolate from Zambia were cloned into the new vector and infective RNAs were generated for each construct to inoculate N. benthamiana plants. His-tagged proteins were purified from inoculated leaves using immobilized metal affinity chromatography (IMAC) as detected by Coomassie blue staining and proteins were further characterized in Western blot assays using a commercial anti-6xHis mAb and specific polyclonal antisera for each protein. While yields obtained for the VPl-His protein after purification were similar to those in crude extracts obtained with the previous TMV-VPl vector, p24-His yields were 10-15 times higher than those of VPl-His. Twenty-five grams of TMV-p24-HISc inoculated leaves were processed to obtain 2.5mg of isolated p24-His and the recombinant protein was inoculated in rabbits to test immunogenicity and antigenic integrity of the plant-produced p24-His. Animals developed a strong and specific humoral response to the p24-His after the first booster and immune sera was able to recognize the native p24 from a different clade expressed on the surface of the HIV-1 chronically infected HUT78/ARV T-cell line. Importantly, the recombinant p24-His proved its efficiency by confirming the serology of 117 samples previously tested by two rapid HIV-1 tests, thus representing an excellent alternative for production of highly specific diagnostic reagents for HIV endemic regions in the developing world.
机译:先前已经报道了通过使用基于烟草花叶病毒的载体(TMV-30B)在本氏烟草中从口蹄疫病毒(FMDV)和牛疱疹病毒(BHV-1)产生结构蛋白。描述了TMV-30B-HISc载体的开发,该载体是向表达的外源蛋白质添加C端组氨酸(His)序列的新版本。将来自赞比亚的进化枝C HIV-1分离株的FMDV VP1蛋白和核心蛋白p24的编码序列克隆到新载体中,并为每种构建体产生感染性RNA,以接种本氏烟草。如通过考马斯亮蓝染色所检测的那样,使用固定的金属亲和色谱法(IMAC)从接种的叶子中纯化了带组氨酸标签的蛋白质,并使用商用抗6xHis mAb和每种蛋白质的特异性多克隆抗血清在蛋白质印迹分析中进一步表征了蛋白质。尽管纯化后获得的VP1-His蛋白的产量与使用以前的TMV-VP1载体获得的粗提物中的产量相似,但p24-His的产量却比VP1-His高10-15倍。处理25克TMV-p24-HISc接种的叶子以获得2.5mg分离的p24-His,并将重组蛋白接种在兔子中以测试植物产生的p24-His的免疫原性和抗原完整性。在第一个加强免疫后,动物对p24-His产生了强烈而特殊的体液反应,免疫血清能够从HIV-1慢性感染的HUT78 / ARV T细胞系表面表达的不同进化枝中识别出天然p24。重要的是,重组p24-His证实了先前通过两次快速HIV-1检测所检测的117个样品的血清学特性,从而证明了其效率,从而为生产针对发展中国家HIV流行地区的高特异性诊断试剂提供了极好的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号